Role of chemokines and chemokine receptors in prostate cancer development and progression.

Cancer Statistics, 2008

Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184 · see citing works

Screening and Prostate-Cancer Mortality in a Randomized European Study

Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., KWIATKOWSKI, M. K., Lujan, M., Lilja, H. G., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,016 · see citing works

Chemokines

Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859 · see citing works

The Biology of Chemokines and their Receptors

Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · see citing works

Inflammation in prostate carcinogenesis

Marzo, A. M. D., Platz, E. A., Sutcliffe, S. S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2090 · Cited by 1,615 · see citing works

Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes

Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,535 · see citing works

Chemokines and disease

Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357 · see citing works

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264 · see citing works

Chemokines and Cell Migration in Secondary Lymphoid Organs

Cyster, J. G. (1999) · Science · doi:10.1126/science.286.5447.2098 · Cited by 1,029 · see citing works

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.

Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 994 · see citing works

Mechanisms of normal and tumor-derived angiogenesis

Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809 · see citing works

The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis

Brat, D. J., Bellail, A. C., & Meir, E. G. V. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760 · see citing works

Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study

Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680 · see citing works

Human prostate cancer risk factors

Bostwick, D. G., BURKE, H. B., Djakiew, D., Euling, S. Y., Ho, S., Landolph, J. R., MORRISON, H. I., Sonawane, B. R., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 644 · see citing works

Osteoblasts in prostate cancer metastasis to bone

Logothetis, C. J., & Lin, S.-H. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1528 · Cited by 613 · see citing works

Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality

Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520 · see citing works

Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study

Giovannucci, E. L., Liu, Y., Platz, E. A., Stampfer, M. J., & Willett, W. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22788 · Cited by 513 · see citing works

Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men

Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., Stephens, R. M., Caporaso, N. E., Loffredo, C. A., & Ambs, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2608 · Cited by 512 · see citing works

Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

Hendrix, C. W., Flexner, C. W., MacFarland, R. T., Giandomenico, C. M., Fuchs, E. J., Redpath, E., Bridger, G. J., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 503 · see citing works

Prostate cancer epidemiology

Ann, W. H. (2006) · Frontiers in bioscience · doi:10.2741/1891 · Cited by 447 · see citing works

Chemokines: agents for the immunotherapy of cancer?

Homey, B., Müller, A., & Zlotnik, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri748 · Cited by 398 · see citing works

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Hendrix, C. W., Collier, A. C., Lederman, M. M., Schols, D., Pollard, R. B., Brown, S., Jackson, J. B., Coombs, R. W., Glesby, M. J., Flexner, C. W., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137371.80695.ef · Cited by 367 · see citing works

MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT

Chung, L. W. K., Baseman, A. G., Assikis, V. J., & Zhau, H. E. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 358 · see citing works

Chemokines in cancer

Vicari, A. P., & Caux, C. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00033-8 · Cited by 351 · see citing works

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 335 · see citing works

Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)

Homey, B., Wang, W., Soto, H., Buchanan, M. E., Wiesenborn, A., Catron, D., Müller, A., McClanahan, T. K., Dieu‐Nosjean, M., Orozco, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3465 · Cited by 332 · see citing works

Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion

Shukla, S., MacLennan, G. T., Hartman, D. J., Fu, P., Resnick, M. I., & Gupta, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22862 · Cited by 316 · see citing works

Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis

Robert, G., Descazeaud, A., Nicolaı̈ew, N., Terry, S., Sirab, N., Vacherot, F., Maillé, P., Allory, Y., & TAILLE, A. D. L. (2009) · The Prostate · doi:10.1002/pros.21027 · Cited by 279 · see citing works

Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer

Araki, S., Omori, Y., Lyn, D. A., Singh, R. K., Meinbach, D. M., Sandman, Y., Lokeshwar, V. B., & Lokeshwar, B. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1162 · Cited by 275 · see citing works

Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study

Collin, S. M., Martin, R. M., Metcalfe, C. D., Gunnell, D., Albertsen, P. C., Neal, D. E., Hamdy, F. C., Stephens, P. J., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272 · see citing works

Macrophage Inflammatory Protein 3α Is Involved in the Constitutive Trafficking of Epidermal Langerhans Cells

Charbonnier, A.-S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., & Maurer, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1755 · Cited by 267 · see citing works

Chemokines in neoplastic progression

Zlotnik, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.004 · Cited by 266 · see citing works

Organ selectivity in metastasis: regulation by chemokines and their receptors

Ben‐Baruch, A. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9097-3 · Cited by 264 · see citing works

S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cells

Hermani, A., DESERVI, B., Medunjanin, S., Tessier, P. A., & Mayer, D. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.013 · Cited by 262 · see citing works

Involvement of the interferon‐γ–induced T cell–attracting chemokines, interferon‐γ–inducible 10‐kd protein (CXCL10) and monokine induced by interferon‐γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome

Ogawa, N., Li, P., Zhenjun, L., Takada, Y., & Sugai, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10577 · Cited by 214 · see citing works

Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer

Murphy, C., McGurk, M., Pettigrew, J., Santinelli, A., Roberta Mazzucchelli, A., Johnston, P. G., Montironi, R., & Waugh, D. J. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1518 · Cited by 213 · see citing works

Quality of Life: Radical Prostatectomy Versus Radiation Therapy for Prostate Cancer

Lim, A. J., Brandon, A. H., Fiedler, J. A., Brickman, A. L., Boyer, C. I., Raub, W. A., & Soloway, M. S. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)66881-2 · Cited by 212 · see citing works

Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB Activation

Kukreja, P., Abdel‐Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209 · see citing works

Cutting Edge: Identification of the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the Chemokine TECK

Zaballos, Á., Gutiérrez, J., Varona, R., Ardavı́n, C., & Márquez, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5671 · Cited by 203 · see citing works

30-Day Mortality and Major Complications after Radical Prostatectomy: Influence of Age and Comorbidity

Alibhai, S. M. H., Leach, M., TOMLINSON, G. A., Krahn, M. D., Fleshner, N. E., Holowaty, E. J., & Naglie, G. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji313 · Cited by 202 · see citing works

Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells

Moore, B. B., Arenberg, D. A., Stoy, K., Morgan, T., Addison, C., Morris, S. B., Glass, M., Wilke, C. A., Xue, Y., Sitterding, S. M., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65404-1 · Cited by 200 · see citing works

Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program

RIETBERGEN, J. B. W., Kruger, A. E. B., Ries Kranse, C., & Schröder, F. H. (1997) · Urology · doi:10.1016/s0090-4295(97)00100-3 · Cited by 199 · see citing works

Inflammation and Chronic Prostatic Diseases: Evidence for a Link?

Sciarra, A., Silverio, F. D., Salciccia, S., Gomez, A. M. A., Gentilucci, A., & Gentile, V. (2007) · European Urology · doi:10.1016/j.eururo.2007.06.038 · Cited by 196 · see citing works

Chemokines in tumor progression and metastasis

Tanaka, T. T., Bai, Z., Srinoulprasert, Y., Yang, B., Hayasaka, H., & Miyasaka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00059.x · Cited by 190 · see citing works

Macrophages promote angiogenesis in human breast tumour spheroids in vivo

Bingle, L., Lewis, C. E., Corke, K. P., Reed, M., & Brown, N. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602901 · Cited by 190 · see citing works

Chemokine receptors and melanoma metastasis

Murakami, T., Cardones, A. R., & Hwang, S. T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.03.002 · Cited by 184 · see citing works

Identification of Single C Motif-1/Lymphotactin Receptor XCR1

Yoshida, T., Imai, T., Kakizaki, M., Nishimura, M., Takagi, S., & Yoshie, O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16551 · Cited by 170 · see citing works

Chemokines in tumor angiogenesis and metastasis

Singh, S., Sadanandam, A., & Singh, R. K. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9068-9 · Cited by 168 · see citing works

Population-Based Study of Relationships Between Hospital Volume of Prostatectomies, Patient Outcomes, and Length of Hospital Stay

Yao, S., & Lu‐Yao, G. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1950 · Cited by 167 · see citing works

Point Mutation Causing Constitutive Signaling of CXCR2 Leads to Transforming Activity Similar to Kaposi’s Sarcoma Herpesvirus-G Protein-Coupled Receptor

Burger, M., Burger, J. A., Hoch, R. C., Oades, Z. G., Takamori, H., & Schraufstätter, I. U. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2017 · Cited by 155 · see citing works

Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote

Denberg, T. D., Melhado, T. V., & Steiner, J. F. (2006) · Cancer · doi:10.1002/cncr.22033 · Cited by 149 · see citing works

Infection after transrectal core biopsies of the prostate

Aus, G., Ahlgren, G., Bergdahl, S., & Hugosson, J. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.01014.x · Cited by 147 · see citing works

The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers

Darash-Yahana, M., Gillespie, J. W., Hewitt, S. M., Chen, Y.-Y. K., Maeda, S., Stein, I., Singh, S. P., Bedolla, R. B., Peled, A., Troyer, D. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006695 · Cited by 143 · see citing works

Screening and Prostate-Cancer Mortality in a Randomized European Study

Lawton, C. A. (2010) · Yearbook of Oncology · doi:10.1016/s1040-1741(09)79428-x · Cited by 138 · see citing works

Chemokine Regulation of Normal and Pathologic Immune Responses

Christopherson, K. W., & Hromas, R. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-388 · Cited by 137 · see citing works

Prostatitis, Sexually Transmitted Diseases, and Prostate Cancer: The California Men's Health Study

Cheng, I. C., Witte, J. S., Jacobsen, S. J., Haque, R., Quinn, V. P., Quesenberry, C. P., Caan, B. J., & Eeden, S. K. V. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008736 · Cited by 133 · see citing works

Health Outcomes After External-Beam Radiation Therapy for Clinically Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study

Hamilton, A. S., Stanford, J. L., Gilliland, F. D., Albertsen, P. C., Stephenson, R. A., Hoffman, R. M., Eley, J. W., Harlan, L. C., & Potosky, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2517 · Cited by 131 · see citing works

Emerging roles of chemokines in prostate cancer

Vindrieux, D., Escobar, P., & Lazennec, G. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0109 · Cited by 127 · see citing works

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention

Nelson, W. G., Marzo, A. M. D., & DeWeese, T. L. (2001) · Urology · doi:10.1016/s0090-4295(00)00939-0 · Cited by 122 · see citing works

Manipulating the chemokine‐chemokine receptor network to treat cancer

Ruffini, P. A., Morandi, P., Cabıoğlu, N., Altundağ, K., & Cristofanilli, M. (2007) · Cancer · doi:10.1002/cncr.22706 · Cited by 114 · see citing works

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

Fowler, F. J., COLLINS, M. M., Corkery, E. W., Elliott, D. B., & Barry, M. J. (2002) · Cancer · doi:10.1002/cncr.10656 · Cited by 110 · see citing works

NE-10 Neuroendocrine Cancer Promotes the LNCaP Xenograft Growth in Castrated Mice

Jin, R. J., Wang, Y., Masumori, N., Ishii, K., Tsukamoto, T., Shappell, S. B., Hayward, S. W., Kasper, S., & Matusik, R. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3117 · Cited by 109 · see citing works

Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate

Yanamandra, K., Alexeyev, O. A., Zamotin, V., Srivastava, V., Shchukarev, A., Brorsson, A., Tartaglia, G. G., Vogl, T., Kayed, R., Wingsle, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005562 · Cited by 108 · see citing works

Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs

Singh, R. K., & Lokeshwar, B. L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-57 · Cited by 105 · see citing works

Expression of interleukin‐8 gene in radical prostatectomy specimens is associated with advanced pathologic stage

Uehara, H., Troncoso, P., Johnston, D. A., Bucana, C. D., Dinney, C. P., Dong, Z., Fidler, I. J., & Pettaway, C. A. (2005) · The Prostate · doi:10.1002/pros.20223 · Cited by 97 · see citing works

Chemokine-Chemokine Receptor Network in Immune Cell Trafficking

Kim, C. H. (2004) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008043339712 · Cited by 95 · see citing works

CCR11 Is a Functional Receptor for the Monocyte Chemoattractant Protein Family of Chemokines

Schweickart, V. L., Epp, A., Raport, C. J., & Gray, P. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9550 · Cited by 94 · see citing works

CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility

Hirata, H., Hinoda, Y., Kikuno, N., Kawamoto, K., Dahiya, A. V., Suehiro, Y., Tanaka, Y., & Dahiya, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0859 · Cited by 94 · see citing works

The role of inflammation and infection in the pathogenesis of prostate carcinoma

Wagenlehner, F. R. A., Elkahwaji, J. E., Ferran Algaba, B., Johansen, T. E. B., Naber, K. G., Härtung, R., & Weidner, W. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07091.x · Cited by 86 · see citing works

Inflammation and Prostate Cancer

Vasto, S., Carruba, G., Candore, G., Italiano, E., Bona, D. D., & Caruso, C. (2008) · Future Oncology · doi:10.2217/14796694.4.5.637 · Cited by 80 · see citing works

Brachytherapy for Prostate Cancer: A Systematic Review

Koukourakis, G. V., Kelekis, N., Armonis, V., & Kouloulias, V. (2009) · Advances in Urology · doi:10.1155/2009/327945 · Cited by 76 · see citing works

Multi-faceted roles for CXC-chemokines in prostate cancer progression

Waugh, D. J. J. (2008) · Frontiers in bioscience · doi:10.2741/3025 · Cited by 58 · see citing works

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation

Jongsma, J., Oomen, M. H., Noordzij, M. A., van Weerden, W. M., Martens, G. J. M., van der Kwast, T., Schröder, F. H., & van Steenbrugge, G. J. (2002) · The Prostate · doi:10.1002/pros.10049 · Cited by 57 · see citing works

The “Emigration, Migration, and Immigration” of Prostate Cancer

Pienta, K. J., & Loberg, R. D. (2005) · Clinical Prostate Cancer · doi:10.3816/cgc.2005.n.008 · Cited by 57 · see citing works

How Older Patients' Treatment Preferences Are Influenced by Disclosures About Therapeutic Uncertainty: Surgery Versus Expectant Management for Localized Prostate Cancer

Mazur, D. J., & Merz, J. F. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01863.x · Cited by 51 · see citing works

Sexually Transmitted Diseases and Sexual Function

Sadeghi‐Nejad, H., Wasserman, M., Weidner, W., Richardson, D., & Goldmeier, D. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01622.x · Cited by 50 · see citing works

New insights into the role of CXCR4 in prostate cancer metastasis

Gladson, C. L., & Welch, D. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.11.7218 · Cited by 42 · see citing works

Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises

Aragon‐Ching, J. B., Madan, R. A., & Dahut, W. L. (2010) · Journal of Oncology · doi:10.1155/2010/361836 · Cited by 33 · see citing works

Androgen receptor abnormalities in castration-recurrent prostate cancer.

Nacusi, L. P., & Tindall, D. J. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.34 · Cited by 27 · see citing works

Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis

Civenni, G., & Sommer, L. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.003 · Cited by 11 · see citing works

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation

Jongsma, J., Oomen, M. H., Noordzij, M. A., et al. (2002) · The Prostate · doi:10.1002/pros.10049.abs · Cited by 5 · see citing works

[Expressions of bacterial 16S rRNA, IL-1beta, TNF-alpha and NGF in prostate tissues].

Xie, H., Huang, H., Yang, Y.-R., He, Q.-X., Zhu, Q.-J., & Chen, J.-O. (2010) · PubMed · Cited by 3 · see citing works

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works

Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study

Zeig‐Owens, R., Webber, M. P., Hall, C. B., Schwartz, T. M., Jaber, N., Weakley, J., Rohan, T. E., Cohen, H. W., Derman, O., Aldrich, T. K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60989-6 · Cited by 139 · see citing works

Epigenetic Regulation of Inflammatory Cytokines and Associated Genes in Human Malignancies

Yasmin, R., Siraj, S., Hassan, A., Khan, A. R., Abbasi, R., & Ahmad, N. (2015) · Mediators of Inflammation · doi:10.1155/2015/201703 · Cited by 118 · see citing works

CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation

Kuo, P., Shen, K., Hung, S., & Hsu, Y. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs299 · Cited by 103 · see citing works

CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition

Lu, Y., Dong, B., Xu, F., Xu, Y., Pan, J., Song, J., Zhang, J., Huang, Y., & Xue, W. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0434-3 · Cited by 93 · see citing works

A high‐fat diet enhances proliferation of prostate cancer cells and activates MCP‐1/CCR2 signaling

Huang, M., Narita, S., Numakura, K., Tsuruta, H., Saito, M., Inoue, T., Horikawa, Y., Tsuchiya, N., & Habuchi, T. (2012) · The Prostate · doi:10.1002/pros.22531 · Cited by 68 · see citing works

Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression

Salazar, N., Castellan, M. A., Shirodkar, S. S., & Lokeshwar, B. L. (2013) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2013006905 · Cited by 67 · see citing works

Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer

Zhuo, C., Wu, X., Li, J., Hu, D., Jian, J., Chen, C., Zheng, X., & Yang, C. (2018) · Bioscience Reports · doi:10.1042/bsr20180580 · Cited by 56 · see citing works

Redox-Mediated and Ionizing-Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment

Miao, L., Holley, A. K., Zhao, Y., Clair, W. H. S., & Clair, D. K. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5637 · Cited by 41 · see citing works

The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module

Chen, K., Wu, K., Jiao, X., Wang, L., Ju, X., Wang, M., Sante, G. D., Xu, S., Wang, Q., Li, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-0611 · Cited by 39 · see citing works

Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells

Han, I., Kim, J., Jang, K., & Ryu, J. (2019) · The Prostate · doi:10.1002/pros.23826 · Cited by 38 · see citing works

Proteasome Inhibition by Bortezomib Increases IL-8 Expression in Androgen-Independent Prostate Cancer Cells: The Role of IKKα

Manna, S., Singha, B., Phyo, S. A., Gatla, H. R., Chang, T., Sanacora, S., Ramaswami, S., & Vancurova, I. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300895 · Cited by 32 · see citing works

The Osteoblastic and Osteoclastic Interactions in Spinal Metastases Secondary to Prostate Cancer

Dushyanthen, S., Cossigny, D. A. F., & Quan, G. M. Y. (2013) · Cancer Growth and Metastasis · doi:10.4137/cgm.s12769 · Cited by 29 · see citing works

Molecular determinants of prostate cancer metastasis

Rycaj, K., & Tang, D. G. (2017) · Oncotarget · doi:10.18632/oncotarget.21085 · Cited by 27 · see citing works

Somatostatin receptors as a new active targeting sites for nanoparticles

Abdellatif, A. A. H., Aldalaen, S., Faisal, W., & Tawfeek, H. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.05.014 · Cited by 26 · see citing works

Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor

Zhu, H., & Garcia, J. A. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0300-1 · Cited by 25 · see citing works

Antioxidant Treatment Promotes Prostate Epithelial Proliferation in Nkx3.1 Mutant Mice

Martinez, E. E., Anderson, P. D., Logan, M., & Abdulkadir, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046792 · Cited by 25 · see citing works

Identification of aberrant gene expression associated with aberrant promoter methylation in primordial germ cells between E13 and E16 rat F3 generation vinclozolin lineage

Taguchi, Y. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s18-s16 · Cited by 23 · see citing works

Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer

Wang, S., Clarke, P. A. G., Davis, R., Mumuni, S., & Kwabi‐Addo, B. (2016) · Cytokine · doi:10.1016/j.cyto.2016.07.006 · Cited by 22 · see citing works

Role of Tumor Suppressor Protein p53 in Apoptosis and Cancer Therapy

Naga Deepthi, C. H., Kumar, V. P., babu, R., & darshini, U. I. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-001 · Cited by 20 · see citing works

CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma

Chen, N., Jiang, X. Y., Wang, J., Wu, T., Cheng, B., & Xia, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3803-6 · Cited by 20 · see citing works

Do androgen deprivation drugs affect the immune cross-talk between mononuclear and prostate cancer cells?

Salman, H., Bergman, M., Blumberger, N., Djaldetti, M., & Bessler, H. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.12.007 · Cited by 15 · see citing works

Biomarkers and their Role in Premonition, Interpretation and Treatment of Cancer

Sai, Y. R. K. M., Dattatreya, A., Anand, S. Y., & Mahalakshmi, D. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-002 · Cited by 11 · see citing works

Extensive serum cytokine analysis in patients with prostate cancer

Gong, D., Wang, Y., Wang, Y., Chen, X., Chen, S., Wang, R., Liu, L., Duan, C., & Luo, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154810 · Cited by 10 · see citing works

Immuno Defense Mechanism against Tumors

Naga Anusha, P., Siddiqui, A., & Hima Bindu, A. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-005 · Cited by 8 · see citing works

Epigenetic Changes of the Immune System with Role in Tumor Development

Florea, I. D., & Karaoulani, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8751-1_11 · Cited by 6 · see citing works

The C-X-C Motif Chemokine Ligand 5, Which Exerts an Antioxidant Role by Inducing HO-1 Expression, Is C-X-C Motif Chemokine Receptor 2-Dependent in Human Prostate Stroma and Cancer Cells

Chang, K., Chen, S., Hsu, S.-Y., Sung, H., Lin, W.-Y., Tsui, K.-H., Lin, Y., Hou, C., & Juang, H. (2024) · Antioxidants · doi:10.3390/antiox13121489 · Cited by 4 · see citing works

The Influence of Environmental and Genetic Factors on Various Disorders and Diseases

Tripathy, K., & Nanda, T. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s11-001 · Cited by 4 · see citing works

Epigenetic and Therapeutic Analysis of various Neurological Disorders

Tripathy, K. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000111 · Cited by 3 · see citing works

Epidemiology and Treatment for Thyroid Cancer

Srilatha, B., Hima Bindu, A., & Soumya, D. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-011 · Cited by 3 · see citing works

Clinical biomarkers for cancer recognition and prevention: A novel approach with optical measurements

Latini, G., Felice, C. D., Barducci, A., Dipaola, L., Gentile, M., Andreassi, M. G., Correale, M., & Bianciardi, G. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170050 · Cited by 3 · see citing works

Organ Specific Cancers - Recent Advances in Diagnosis and Treatment

Shalini, G., Remya, R. S., Gayathri, G., & Vishalakshi, V. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-006 · Cited by 2 · see citing works

Significance of Dietary Antioxidants in Averting Cancer

Subrahmanyam, V. V., & Ramachandran, R. P. (2012) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000127 · Cited by 2 · see citing works

Quantitative Analysis of Bortezomib-Induced IL-8 Gene Expression in Ovarian Cancer Cells

Singha, B., Phyo, S. A., Gatla, H. R., & Vancurova, I. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0928-5_27 · Cited by 2 · see citing works

A Compendium of Cancer Therapeutic Strategies and their Modality

Lakshmi Prasanna, N., & Sathish Kumar, D. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-010 · Cited by 1 · see citing works

Part of Tumor Suppressor Protein p53 in Apoptosis and Cancer Therapy

Tripathi, V. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences · Cited by 1 · see citing works

REDOX-REGULATED RELB-AR AXIS MEDIATES PROSTATE SPECIFIC ANTIGEN EXPRESSION: INSIGHT IN PROSTATE CANCER RESPONSE TO RADIATION THERAPY

Lu, M. (2013) · UKnowledge (University of Kentucky)

Inflamación y cáncer de próstata: implicaciones biológicas y posible utilidad clínica

Reyes, N., & Correa, O. (2013) · IATREIA · doi:10.17533/udea.iatreia.15143

Vaccine Potentiality and Stem Cells Enhancing Cure to Cancer

Parthasarathi, D., & Palki, D. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-008

An Eye on Breast and Prostate Cancers

Gandi, S., Phaneendra, M., Anamika, K., & Jyothi, J. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s17-003

The Impact of Environmental and Genetic Factors on different Disorders and Diseases

Tripathi, V. (2015) · Research and Reviews: Journal of Microbiology and Biotechnology

Biomarkers and their Role in Premonition, Elucidation and Treatment of Cancer

Tripathi, V. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences

Genetic Effect and Environmental Analysis of Various Genetic Diseases

Tripathy, K. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences

Research and Reviews: Journal of Medical and Health Sciences Part of Tumor Suppressor Protein p53 in Apoptosis and Cancer Therapy

Tripathi, V. (2015)

Mechanisms of Prostate Tumor Initiation: Interplay of Antioxidants and Genetic Alterations

Martinez, E. E. (2013)

The relationship between chemokines, inflammation, and prostate cancer

Yang, L. (2015) · Xiandai yufang yixue · Cited by 1 · see citing works

Emerging roles of chemokines in prostate cancer

Vindrieux, D., Escobar, P., & Lazennec, G. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0109 · Cited by 127 · see citing works

Prostate Cancer

Rani, A., Prokar Dasgupta, A., & Murphy, J. J. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.007 · Cited by 98 · see citing works

Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis

Mughees, M., Kaushal, J., Sharma, G., Wajid, S., Batra, S. K., & Siddiqui, J. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.017 · Cited by 84 · see citing works

The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management

Ullah, A., Jiao, W., & Shen, B. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00591-9 · Cited by 37 · see citing works